A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Active, not recruiting · NCT02763566 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-02-05 | NCT02763566 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
45 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.